Australia To Bring Complex Stem Cell Therapies Within Regulatory Fold
Executive Summary
Taking cue from the regulators in the US and the EU, the Australian government is developing a policy to formally regulate the increasingly complex field of stem cell therapies. The new regulatory approach is to be supported by detailed guidance from the Therapeutic Goods Administration to help legitimate products gain approval.
You may also be interested in...
Australia Clarifies Regulatory Oversight Of Human Tissues And Cell Products
New rules on the regulation of autologous human cell and tissue products have been introduced in Australia, together with clearer definitions of biological products.
US FDA's Drug Seizures Seen As Most Significant Aspect Of Stem Cell Crackdown
Former Office of Compliance and Biologics Quality Deputy Director Mark Schwartz says dishonest players have not often seen serious enforcement actions from the agency.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.